The study about the effect of combination therapy of active form of vitamin D and lanthanum carbonate for serum concentration of FGF23
Not Applicable
- Conditions
- chronic kidney disease
- Registration Number
- JPRN-UMIN000030503
- Lead Sponsor
- Fujita Health University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
We exclude patients who meet conditions below: 1. patients who have taken active form of vitamin D within 4 weeks. 2. patients who have taken any supplements including natural form of vitamin D within 4 weeks. 3. patients who have taken any phosphate binders within 4 weeks. 4. patients who do not agree with the study 5. patients whom one or more investigators do not regard as appropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change of serum FGF23 level after 24 weeks
- Secondary Outcome Measures
Name Time Method changes of laboratory data including other bone metabolic markers, results of echocardiogram, changes of aortic calcification score, amounts of active form of vitamin D or lanthanum carbonate